Keller and Heckman offers global food and drug services to its clients. Our comprehensive and extensive food and drug practice is one of the largest in the world. We promote, protect, and defend products made by the spectrum of industries regulated by the U.S. Food and Drug Administration (FDA), the European Commission and Member States authorities in the European Union (EU) and similar authorities throughout the world. The products we help get to market include foods, pharmaceuticals, medical devices, veterinary products, dietary supplements, and cosmetics. In addition, we have a very comprehensive practice in the regulation of packaging materials for food, drugs, and cosmetics and other food-contact articles. We represent clients in addressing all issues relating to these products, including the suitability of their composition, inspection of manufacturing facilities, labeling and advertising, recall procedures, quality assurance programs, and appropriate responses to consumer complaints and tampering incidents. We also vigorously defend our clients when threatened by unwarranted action by competitors or regulatory authorities. We also have substantial experience conducting "due diligence" audits of marketed products, labeling, advertising claims, and manufacturing operations, both for the clients' internal control purposes and as part of product line or corporate acquisitions.
More Legal and Business Bylines From Food and Drug Law at Keller and Heckman
- Study Finds One-Third of Chocolate Contains High Levels of Heavy Metals - (Posted On Monday, October 30, 2023)
- FDA Publishes FY 2021 Pesticide Residue Report - (Posted On Wednesday, October 25, 2023)
- Lawsuit Alleges Panera’s Caffeinated Lemonade Caused Death - (Posted On Tuesday, October 24, 2023)
- FDA Deputy Commissioner for Human Foods Expresses Commitment to Human Foods Program Framework - (Posted On Monday, October 23, 2023)
- APHIS Releases Revised Guidance for Genetically Engineered Microorganism Applications - (Posted On Thursday, October 19, 2023)
- Califf Provides Update on Front-of-Package Labeling - (Posted On Wednesday, October 18, 2023)
- Public Meeting on Strategies to Reduce Added Sugar Consumption Set for November - (Posted On Tuesday, October 17, 2023)
- FDA Publishes Updated Prior Notice of Imported Food Guidance Document - (Posted On Monday, October 16, 2023)
- FDA Updates Compliance Program for Infant Formula - (Posted On Wednesday, October 11, 2023)
- CA Governor Newsom Signs Food Additive Ban into Law - (Posted On Tuesday, October 10, 2023)
Keller and Heckman’s Food and Drug Law Practice Group is a Go-To Thought Leader for 2021 for its coverage of Food Labeling Class Action Lawsuits and Regulatory news. The group regularly provides interesting, comprehensive news on topics ranging from class-action lawsuits involving Snack Foods lacking real Wasabi and Canned Green Beans inaccurately claiming to be preservative-free, to proposed federal legislation regulating CBD in food products. NLR readers appreciate the group’s efforts to break down lawsuits and pending legislation impacting the nation's food supply.
The National Law Review Recognizes Keller and Heckman’s Food and Drug Law Practice Group as Go-To Thought Leaders for the firm’s contributions on FDA Regulations and guidelines. Keller and Heckman’s expansive FDA coverage included: proposed rules expanding food traceability and record-keeping requirements, new guidance for animal food additives, a final rule concerning gluten-free food labeling, and approval of a new peanut allergy drug. Addressing the COVID-19 crisis, Keller & Heckman provided news about warnings required by the FDA for Purell and other actions about hand sanitizer and additional Coronavirus prevention and cure claims, the FDA’s and OSHA’s employee health and food safety checklist(s) and COVID-19 best practices for retail and restaurants and COVID-19 Guidance to U.S. food exporters. The firm’s most frequent FDA / Food and Drug Law attorney contributors to the NLR include Azim Chowdhury, Sheila A. Millar, Evangelia Pelonis, Natalie Rainer and LieAnn Van-Tull.